Alpine Associates Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Alpine Associates Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,692,538	Closed	-$106M	–	56
2023 Q2	$106M	Buy	+2,692,538	New	+$95M	4.77%	7

Alpine Associates Management's ISEE Position: Q3 2023 in Review

Alpine Associates Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 2,692,538 shares — an estimated $106M sold.

Alpine Associates Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $106M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Alpine Associates Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Alpine Associates Management sold 2,692,538 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $106M.
Alpine Associates Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Alpine Associates Management's IVERIC bio, Inc. Common Stock position peaked at $106M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Alpine Associates Management's 13F filing for Q3 2023, filed 8 Nov 2023.